Clinical Trial Update: Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating panitumumab, capecitabine, and oxaliplatin with external beam radiotherapy for esophageal cancer has completed accrual with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Vectibix (panitumumab)
• Xeloda (capecitabine)

Snippet

Sponsor: Brian Czito | Conditions: Cancer of the Esophagus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-08-07